Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
VA Office of Research and Development
In this single site clinical trial, intended to evaluate the safety and efficacy of repeated doses of ketamine in conjunction with prolonged exposure (PE) therapy for PTSD. Veterans who meet criteria for PTSD and the additional inclusion and exclusion criteria will be randomized to one of two treatment arms (placebo plus PE vs ketamine plus PE). Participants receive the study drug via intravenous infusion once per week for 3-weeks.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
male or female Veterans between the ages of 18 and 75 years
diagnosis of PTSD
ability to provide written informed consent
You may not be if
females who are currently pregnant or breastfeeding
current high risk for suicide
history of moderate/severe head injury
history of psychosis
current episode of mania/hypomania
severe substance and/or alcohol use disorder in the last 6 months
